rs369447363
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_153240.5(NPHP3):c.65C>T(p.Ala22Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,578,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_153240.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPHP3 | NM_153240.5 | c.65C>T | p.Ala22Val | missense_variant | Exon 1 of 27 | ENST00000337331.10 | NP_694972.3 | |
NPHP3-AS1 | NR_002811.2 | n.542G>A | non_coding_transcript_exon_variant | Exon 1 of 11 | ||||
NPHP3-ACAD11 | NR_037804.1 | n.169C>T | non_coding_transcript_exon_variant | Exon 1 of 45 | ||||
NPHP3-AS1 | NR_152743.1 | n.542G>A | non_coding_transcript_exon_variant | Exon 1 of 5 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 151960Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000140 AC: 29AN: 206718Hom.: 0 AF XY: 0.000155 AC XY: 18AN XY: 116336
GnomAD4 exome AF: 0.000130 AC: 186AN: 1426462Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 95AN XY: 710028
GnomAD4 genome AF: 0.0000987 AC: 15AN: 151960Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74202
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
NPHP3-related disorder Uncertain:1
The NPHP3 c.65C>T variant is predicted to result in the amino acid substitution p.Ala22Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.028% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Inborn genetic diseases Uncertain:1
The c.65C>T (p.A22V) alteration is located in exon 1 (coding exon 1) of the NPHP3 gene. This alteration results from a C to T substitution at nucleotide position 65, causing the alanine (A) at amino acid position 22 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Nephronophthisis 3;C2673885:NPHP3-related Meckel-like syndrome;C3715199:Renal-hepatic-pancreatic dysplasia 1 Uncertain:1
- -
Nephronophthisis Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 22 of the NPHP3 protein (p.Ala22Val). This variant is present in population databases (rs369447363, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with NPHP3-related conditions. ClinVar contains an entry for this variant (Variation ID: 500896). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at